HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 23, 19929-19936, June 8, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 276/23/19929    most recent M004711200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zeibdawi, A. R. Articles by Pryzdial, E. L. G. Search for Related Content PubMed PubMed Citation Articles by Zeibdawi, A. R. Articles by Pryzdial, E. L. G. Social Bookmarking                      What's this?

Mechanism of Factor Va Inactivation by Plasmin
LOSS OF A2 AND A3 DOMAINS FROM A Ca²⁺-DEPENDENT COMPLEX OF FRAGMENTS BOUND TO PHOSPHOLIPID^*

Abed R. Zeibdawi and Edward L. G. Pryzdial

From the Research and Development Department, the Canadian Blood Services and the Department of Biochemistry, Microbiology, and Immunology, the University of Ottawa, Ottawa, Ontario K1G 4J5, Canada

The coagulation cofactor Va (FVa) is a noncovalent heterodimer consisting of a heavy chain (FVaH) and a light chain (FVaL). Previously, the fibrinolytic effector plasmin (Pn) has been shown to inhibit FVa function. To understand this mechanism, the fragmentation profile of human FVa by Pn and the noncovalent association of the derived fragments were determined in the presence of Ca²⁺ using anionic phospholipid (aPL)-coated microtiter wells and large (1 µm) aPL micelles as affinity matrices. Following Pn inactivation of aPL-bound FVa, a total of 16 fragments were observed and their NH₂ termini sequenced. These had apparent molecular weights and starting residues as follows (single letter abbreviation is used): 50(L1766), 48(L1766), 43(Q1828), 40(Q1828), 30(S1546), 12(T1657), and 7(S1546) kDa from FVaL; and 65(A1), 50(A1), 45(A1), 34(S349), 30(L94), 30(M110), and 3 small <5(W457, W457, and K365) kDa from FVaH. Of these, 50(L1766), 48(1766), 43(Q1828), and 40(Q1828) spanning the C1/C2 domains, and 30(L94), but not the similar 30(M110), positioned within the A1 domain remained associated with aPL. These were detected antigenically during Pn- or tissue plasminogen activator-mediated lysis of fibrin clot formed in plasma. Chelation by EDTA dissociated the 30(L94)-kDa fragment, which was observed to associate with intact FVaL upon recalcification, indicating that the Leu-94 to Lys-109 region of the A1 domain plays a critical role in the FVaL and FVaH Ca²⁺-dependent association. By using domain-specific monoclonal antibodies and an assay for thrombin generation, loss of FVa prothrombinase function was coincident with proteolysis at sites in the A2 and A3 domains resulting in their dissociation. Inactivation of FV or FVa by Pn was independent of the thrombophilic R506Q mutation. These results identify the molecular composition of Pn-cleaved FVa that remains bound to membrane as largely A1-C1/C2 in the presence of Ca²⁺ and suggest that Pn inhibits FVa by a process involving A2 and A3 domain dissociation.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				L. L. Molday, W. W. H. Wu, and R. S. Molday Retinoschisin (RS1), the Protein Encoded by the X-linked Retinoschisis Gene, Is Anchored to the Surface of Retinal Photoreceptor and Bipolar Cells through Its Interactions with a Na/K ATPase-SARM1 Complex J. Biol. Chem., November 9, 2007; 282(45): 32792 - 32801. [Abstract] [Full Text] [PDF]

				H. Wakabayashi, J. Freas, Q. Zhou, and P. J. Fay Residues 110-126 in the A1 Domain of Factor VIII Contain a Ca2+ Binding Site Required for Cofactor Activity J. Biol. Chem., March 26, 2004; 279(13): 12677 - 12684. [Abstract] [Full Text] [PDF]

				K. G. Mann and M. Kalafatis Factor V: a combination of Dr Jekyll and Mr Hyde Blood, January 1, 2003; 101(1): 20 - 30. [Full Text] [PDF]